Quantcast Jay La Forest's Pharmacy News
Jay La Forest's Pharmacy News By www.FreePharmacyJobs.com
Pharmacy News - The Products And Services That Drive It Forward.
Jay La Forest's Pharmacy News >> PHARMACEUTICAL INDUSTRY November 27, 2009 members login here
>>  PHARMACEUTICAL INDUSTRY
FDA Approves Agriflu Seasonal Influenza Vaccine
Reuters - 3 Hours ago
Another option to prevent illnesses caused by subtypes A and B influenza virus SILVER SPRING, Md., Nov. 27 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Agriflu for people
FDA Approves Additional Vaccine for 2009 H1N1 Influenza (Swine Flu) HIV and Hepatitis.com
all 1 news articles >>      Add Comment

ALDA Pharmaceuticals signs agreement with Shoppers Drug Mart for ...
Zibb - 4 Hours ago
Companies: Alda Pharmaceuticals Corp (APCSF), Shoppers Drug Mart Corp. (SHDMF) ALDA Pharmaceuticals Corp., a developer of infection control therapeutics, has entered into an agreement with Shoppers Drug
ALDA Pharmaceuticals signs agreement with Shoppers Drug Mart for T36(R) Antiseptic TradingMarkets
ALDA Pharmaceuticals and Shoppers Drug Mart sign distribution agreement News-Medical.Net
all 5 news articles >>      Add Comment

Isis Pharmaceuticals Down 30.5% Since SmarTrend's Sell Recommendation
TradingMarkets - 5 Hours ago
Look up the PowerRating of ISIS and see how it has performed over the past week as well as the current proprietary PowerRating. Nov 27, 2009 (SmarTrend(R) Spotlight via COMTEX) -- ISIS | Quote | Chart
Danaos Down 5.3% Since SmarTrend's Sell Recommendation TradingMarkets
PMI Group Down 40.2% Since SmarTrend's Sell Recommendation - Zibb... Zibb
all 118 news articles >>      Add Comment

Idera Pharmaceuticals and Merck extend research collaboration - Z...
Zibb - 8 Hours ago
Companies: Idera Pharmaceuticals Inc (IDRA), Merck & Co., Inc. (MRK) Idera Pharmaceuticals, a biotechnology company, has reported that Merck & Co, through an affiliate, has extended its research collaboration
Idera Pharmaceuticals and Merck extend research collaboration Therapeutics Daily
all 1 news articles >>      Add Comment

Karo Bio's partner Merck plans to initiate Phase IIa hot flashes ...
Zibb - 8 Hours ago
Company: Merck & Co., Inc. (MRK) Swedish biotechnology company Karo Bio has reported that US-based pharmaceutical group Merck & Co, through an affiliate, plans to enter a clinical Phase IIa trial with
Karo Bio's partner Merck plans to initiate Phase IIa hot flashes trial Therapeutics Daily
Merck & Co takes Karo Bio hot flushes drug into Phase II Pharma Times
all 5 news articles >>      Add Comment

(Tentative) Q3 2009 HEI, Inc. Earnings Release - ESTIMATED
Reuters - 23 Hours ago
HEI, Inc. (HEI) operates two business segments that provide a suite of services from design and development, testing to transitional manufacturing and service contract manufacturing. The Company�s
(Tentative) Q3 2009 MDI, Inc. Earnings Release - ESTIMATED Reuters
(Tentative) Q3 2008 VIOQUEST PHARMACEUTICALS INC Earnings Release - ESTIMATED Reuters
all 2 news articles >>      Add Comment

Is female Viagra' a much-needed remedy or just hard to swallow?
Globe and Mail - 3 Hours ago
Who's afraid of Viagra Woolf? As it happens, quite a few people. Given the prevalence of what is known, controversially, as female sexual dysfunction, the search for a woman's wonder drug is on. And,
Is â??female Viagra' a much-needed remedy or just hard to swallow? Globe and Mail
all 1 news articles >>      Add Comment

Incyte signs license agreement with Novartis for INCB18424 and INCB28060
TradingMarkets - 5 Hours ago
Look up the PowerRating of INCY,NVS and see how it has performed over the past week as well as the current proprietary PowerRating. Nov 27, 2009 (Datamonitor Financial Deals Tracker via COMTEX) -- NVS
Novartis to develop Incyte drugs Pharmacy Europe
Incyte enters collaboration & license pact with Novartis for 2 haematology-oncology PharmaBiz
all 6 news articles >>      Add Comment

North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug
Freshnews.com - 7 Hours ago
Companies mentioned in this article: Cromoz Inc. DURHAM, N.C., Nov. 27 /PRNewswire/ -- Cromoz Inc., located in Research Triangle Park, will initiate water-soluble carbon nanotube-based cancer drug delivery
North Carolina-based Cnanoz Unveils NanoPure to Government Leaders in Hyderabad, Carolina Newswire
North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, E Releases
all 2 news articles >>      Add Comment

UPDATE 1-FDA denies approval for Theravance's pneumonia drug
Interactive Investor International - 3 Hours ago
* FDA asks for additional data * Co says already collected data asked by FDA Nov 27 (Reuters) - Drug developer Theravance Inc said U.S. health regulators did not approve its drug Telavancin for treatment
FDA denies approval for Theravances pneumonia drug Financial 24
all 1 news articles >>      Add Comment

Undiscovered Equities, Inc.: Nutra Pharma's (OTCBB:NPHC) Distributor for Cobroxin,
TradingMarkets - 7 Hours ago
Set_Cookie( 'test', 'none', '', '/', '', '' (Get_Cookie( 'test')) else _uacct sfHover hidePopUp(which) _cfscriptLocation makeRequest(url) sendtofriend(el) (!emailCheck('emailFriendfrom', forname)) (!alphaCheck('Friendfrom',
     Add Comment

4-Star Stocks Poised to Pop: Wal-Mart
Motley Fool - 8 Hours ago
Based on the aggregated intelligence of 145,000-plus investors participating in , the Fool's free investing community, retail behemoth Wal-Mart Stores (NYSE: WMT) With that in mind, let's take a closer
5-Star Stocks Poised to Pop: Exelon Motley Fool via MSN Money
4-Star Stocks Poised to Pop: Sequenom The Money Times
all 6 news articles >>      Add Comment

Natco Pharma plans to fight Teva's citizen petition for Glatiramer Acetate
PharmaBiz - 11 Hours ago
Natco Pharma, a Rs 400 crore Hyderabad-based pharma company, is planning to suitably respond to Teva Pharma's Citizen Petition with the US FDA regarding Glatiramer Acetate product. Teva had alleged, that
INDIA'S NATCO PHARMA FLAYS TEVA FOR FILING CITIZEN PETITION Individual.com
NATCO terms Teva's Citizen Petition a ploy to delay Generic Competition Equity Bulls
all 3 news articles >>      Add Comment

Cardio Drug Micardis Wins EU Nod
Pharmaceutical Technology - 12 Hours ago
The EU has granted approval for Boehringer Ingelheim's Micardis (telmisartan) to prevent morbidity in patients with cardiovascular disease, a leading cause of deaths in Europe. The treatment is the first
     Add Comment

Powerful New Hay Fever Drug Available in EU
Pharmaceutical Technology - 12 Hours ago
Stallergenes has been granted approval in Europe to market Oralair, a powerful new immunotherapy tablet for patients with severe rhinoconjunctivitis caused by grass pollens. The treatment, which was first
     Add Comment

FDA targets illegal pharma websites
Pharmaceutical Technology - 16 Hours ago
Pharmaceutical Technology Europe The FDA has issued 22 Warning Letters to website operators as part of its International Internet Week of Action, a week-long international effort aimed at curbing illegal
     Add Comment

Largest ever study of an antimalarial drug launched
Pharmaceutical Technology - 16 Hours ago
Pharmaceutical Technology Europe An agreement between sanofi-aventis and the Medicines for Malaria Venture (MMV) has lead to the initiation of the largest safety and efficacy study of an antimalarial
     Add Comment

Molecules identified from herbs can be potential drugs to treat Parkinson's disease:
PharmaBiz - 15 Hours ago
Researches conducted on certain ayurvedic herbs have provided hope in identifying a set of anti-parkinsonian molecules that might help to design novel drugs for arresting the progression of Parkinson's
Molecules identified from herbs can be potential drugs to treat Parkinoson's disease: PharmaBiz
all 1 news articles >>      Add Comment

Novartis to terminate research collaboration agreement with Idera Pharma
PharmaBiz - 20 Hours ago
Idera Pharmaceuticals, Inc, announced that Novartis will terminate its research collaboration agreement with the company, effective as of February 21, 2010. 'We appreciate the commitment Novartis scientists
IDRA: Novartis Terminates R&D Collaboration Agreement Individual.com
Novartis to terminate its research collaboration agreement with Idera Pharmaceuticals News-Medical.Net
all 2 news articles >>      Add Comment

GlaxoSmithKline executive becomes president of Chemical Industries Association
Manufacturing Chemist - 21 Hours ago
John Saul, senior vice president of primary manufacturing and engineering for GlaxoSmithKline, has been elected president of the London, UK-based . Saul, who has led the manufacture and supply of active
     Add Comment

Clearwire Communications raises $1,057 million through private placement
TMC Net - 21 Hours ago
(Datamonitor Financial Deals Tracker via COMTEX) -- Clearwire Communications, LLC, a US-based provider of internet services, has raised $1,057 million out of a planned $1,564 million private stock offering.
Jazz Pharmaceuticals raises $120 million through private placement Individual.com
Poniard Pharmaceuticals raises $7.45 million in secondary offering Individual.com
all 14 news articles >>      Add Comment

Pfizer plans R&D center in China
Individual.com - 3 Hours ago
While Pfizer Inc. is downsizing in the United States, including an impending pullout from its former world research-and-development headquarters in New London, the giant pharmaceutical firm plans to expand
Pfizer plans to set up new R&D center in Wuhan Interfax
all 1 news articles >>      Add Comment

CORRECT: (11/25) Teva Files 2nd Citizen's Petition To Block Generic Copaxone
Nasdaq - 6 Hours ago
('Teva Files 2nd Citizen's Petition To Block Generic Copaxone' published at 3: 44 p.m. EST Wednesday misstated the year when a generic Copaxone could enter the market in the 10th paragraph. The correct
     Add Comment

Drug industry targets growth
People's Army Newspaper Online - 3 Hours ago
industry wants to meet 60 percent of market demand by 2010 by producing specialised medicine and improving its distribution network, according to the Drug Administration Department. New stories
     Add Comment

Sun Pharma Announces USFDA Tentative Approval for Generic Strattera® Capsules
United News of India - 3 Hours ago
Source : Sun Pharmaceuticals Industries Ltd (Business Wire India) Category : BUSINESS, LEISURE, HEALTH Sun Pharma announced that the USFDA has granted a tentative approval for an Abbreviated New Drug
Sun Pharma announces USFDA OK for Generic Strattera capsules Financial Express
Sun Pharma's ADHD Generic Tentatively Approved in US Pharmaceutical Technology
all 6 news articles >>      Add Comment

Already a member? Sign in
Email Address:
Password:
Forget your password?

Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms of Use   |   Privacy Policy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.